Company intelligence / Profile preview
Hartington Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
Overview
Hartington Pharmaceuticals is dedicated to the development and production of innovative, natural substance-derived pharmaceutical products, managing clinical trials, manufacturing, and regulatory tasks through subsidiaries in Spain, the UK, and Georgia. The company positions itself as a future leader in phytopharmaceuticals and aspires to global recognition for its efficacy and safety.
- Therapeutic areas
- OncologyPulmonologyDermatologyRheumatology
- Modalities
- Small moleculeBiologicPhytopharmaceutical (natural substance-based drugs)
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Hartington Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hartington Pharmaceuticals.